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     HSA plays an important role in transporting metabolites and drugs throughout the vascular system.  In as 
much as its performance is very vital in the presents of different kinds of ligands at the specific body 
temperatures, its examination is crucial. This molecule can undergo increased glycation in diabetes. Therefore, 
glucose as the one of the most fundamental ligands dealing with albumin in human body is examined in this study 
at 100 mg/dl concentration in correspond to normal condition on human body, 175 mg/dl as a kidney glucose 
tolerance point and also 400 mg/dl as the critical point at the two most important temperatures in diabetic patients. 
Thermal conformational changes of (HSA) are important. These conformational alterations are accompanied by a 
mild alteration of secondary structures. For this reason, possible secondarystructural changes of HSA in presence 
of glucose has beeninvestigated by circular dichroism (CD) using Hepes bufferat the normal temperature 37˚C 
and 42˚C as a high fever condition.UV spectroscopystudies confirmed CD findings and indicate that critical 
concentration of glucoselead to generation of new structural feature of albumin similar to 42
o
C. However, as the 
temperature increases from 37˚C to 42˚C this process is no more capable of responding to glucose concentration 
changes.These results indicate that the native form of HSA is changed in the severe diabetic condition; likewise, 
same consequences can be achieved as the temperature arises from 37˚C to 42˚C. 
 




      Human serum albumin (HSA) as a monomeric 
multidomainglobular protein is the most common 
circulating protein in blood. This molecule 
consistsof 585 amino acids with an average 
molecular weight of66500 Da[1]. This molecule 
representsthe major controllingelement of fluid 
dispersal among body compartments,and the most 
vital factor in regulatingplasma osmotic pressure. 
Furthermore,ligand binding capabilityenabled this 
vital molecule for carrying many endogenous and 
exogenous compounds. In fact, albumininfluences  
pharmacokinetics of many drugs, signifies the chief 
carrier for fatty acids,  control the metabolic change 
of some ligands, transforms possible toxins mild,  
makes up for most of the anti-oxidant capacity of 
human plasma,and shows (pseudo-)enzymatic 
activities [2-4].  Additionally, albumin is a 
biological marker in a number of clinical disorders, 
adaptation mechanisms may be involved[5]. 
Remarkably,a number of factors are identified to 
influence HSA structure and dynamics, like pH, 
temperature, and binding of different ligands[6]. It 
has beenmarked that not onlyprotein activity, 
unfolding, and degradation but also cell functioning 
is highly related to protein glycation. This globular 
heart-shaped molecule contains three homologous 
domains typically specified as I (1–195), II (196–
383), and III (384–585). Thesedomains are 
comparable bothin the amino acid sequence and in 
the secondary and tertiary structures.Amazingly, 
even in thepresence of a wide variety of 
ligandsalbumin  conformation is 
completelypreserved[7-9].From recent studies, 
glycated albumin has biological impact on cell 
physiology and functioning; it is known as a marker 
of diabetes [3, 10, 11]. For instance,a risk factor for 
diabetes mellitus (DM) is urinary albumin excretion, 
which is independent of primary metabolic profile 
and increase of insulin resistance[12, 13].Moreover, 
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glycation has key implications for albumin 
performance and influence on cell.The incubation of 
HSA with glucose results in its non-enzymatic 
glycoxidation in a concentration, incubation time, 
and temperature dependent manner. Non-enzymatic 
glycation of HSA alters its conformation and 
function[14]. In this study, it is proposed that 
glucose binds to HSA and alters the structural 
aspects. Circular dichroism (CD) and UV 
spectroscopic methods,consequently,have been 
appliedto evaluatethe structural modifications of 
human serum albumin in the temperature of 37-
42˚C in the presence and absence of glucose. 
 
MATERIALS AND METHODS 
Materials 
     Human serum albumin was purchased from 
Sigma chemicalCo., USA, The other substances 
ofreagent grade were obtained from Merck 
chemicalCo., Germany; also, the buffer used all 
through thestudy wasHepes 100 mM, pH 7. 
Methods 
CD spectra were recorded by a Jasco J-715 
spectropolarimeter (Japan). Results are expressed as 
ellipticity, [θ] (degree cm2 dmol
−1
), based on a mean 
amino acid residue weight (MRW). This value was 
assumed to be 113 Da for HSA. The molar 
ellipticity was determined as 
[θ]λ = (θ × 100 MRW/cl)  
Where c is the protein concentration in mM, l is the 
length of light path in cm and θ is the measured 
ellipticity in degree at a given wavelength. The data 
were smoothed using the Jasco J-715 software, 
which includes a fast Fourier-transform noise 
reduction routine. All experiments were repeated 
three times. The concentration of the protein 
solution was 0.5mg/ml. Percentage of secondary 
structures was calculated with the method of Chen et 
al.[15]. The UV-V absorption spectra of HSA were 
obtained by Unico spectrophotometer[16]. HSA 
incubated 5 minutes in Hepes buffer 100mM, pH 7 
under the applied conditions and then the spectra 
were taken.The results were presented as 
mean±standard deviation for continuous variables. 
 
RESULT 
    For examining albumin (HSA) exposure to 
glucose, CD technique was applied for detection of 
structural changes of this protein. For understanding 
the role of glucose on albumin structure at fever 
condition the mentioned experiment was repeated at 
42
˚
C (see figure 2). Absorption UV spectroscopy is 
a method that is applied widely in protein studies 
[17-20]. Based on this method it has been reported 
that Acetaminophen as a pain killer induces 
conformational change in human serum albumin 
[20, 21](see figure 3). For more investigation UV 
spectra of albumin in the presence of two 
concentrations of glucose in the range of 
temperatures are provided, and represented in 
figures 4 and 5. 
 
 
Figure 1.  CD spectra of HSA in the presence of 100 
mg/dl,175 mg/dl, and also 400 mg/dl concentrationsof 
glucose in Hepesbuffer 100 mM, pH 7 at 37˚C. Glucose 
concentration decreases from up to down.  
 
Figure 2.  CD spectra of HSA in the presence of 100 
mg/dl,175 mg/dl, and also 400 mg/dl concentrationsof 
glucose in Hepesbuffer 100 mM, pH 7 at 42˚C. Glucose 
concentration decreases from up to down.  
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Figure 3. Acetaminophen induces conformational change in albumin, so the solid part of albumin absorption curve (up curve) is not 






Figure 4. UV spectra of human serum albumin in the 
presence of 150 mg/dl concentration of glucose in the range 






Figure 5. UV spectra of human serum albumin in the 
presence of 400 mg/dl concentration of glucose in the range 
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DISCUSSION 
      HSAas high abundanceprotein in our blood 
has particular tasks[22-24].HSA has remarkable 
ligand binding despite being monomeric; in fact, 
endogenous and exogenous HSA ligand binding 
modulation is includedby ligand-ligand 
competition for the same site as well as by 
intermolecular communication(s) within multiple 
clefts. HSA, furthermore, signifiesa 
prominentbiomarker for many diseases such 
ascancer, ischemia, severe acute graft-versus-host 
disease, and sicknessesthat require monitoring 
glycemic control. Here secondary structural 
changes associated with incubatedHSA with 
glucose in the 100, 175 and 400 mg/dl range in 
both 37˚C and 42˚Chas been studied. Near UV- 
CD is applied widely for the study of tertiary 
structural changes of protein while far UV-CD is 
one of the best ways for studying the secondary 
structural changes of proteins during phase 
transition [25, 26]. Accordingly, far UV-CD 
technique was employed for the determination of 
the effect of glucose on the secondary structure of 
HSA[27]. It can be suggest that, glucose at high 
concentration which is the exact dosage that 
diabetic patients dealing with, shows a highly 
modification in secondary structure of albumin 
which is basically related to β sheets and α helix 
of this molecule. Our calculation shows that 
albumin loses about 4% α-helix component in the 
presence of 400 mg/dl concentration of glucose at 
37
˚
C. It is reported that secondary structural 
change may be accompanied by alteration of 
molecular function[1, 28], so it is an important 
process that glucose induces in albumin structure. 
The100 mg/dl as normal dose of glucose in 
human body and control, 175 mg/dl concentration 
of glucose as a glucose tolerance point for kidney 
and also 400 mg/dl as the critical point for 
glucose in diabetic conditionare selected. As it is 
depicted in the figure 2 this structural transition is 
not seen at 42
˚
C temperature. The 42
˚
C 
temperature corresponds to sever condition of 
fever in human body. Previous study [6] showed 
that 42
˚
C changes conformational structure of 
albumin in a reversible manor.In both cases 
conformational changes are accompanied by mild 
alteration of α-helix component of albumin. 
As it is shown in figure 3[20], UV spectroscopy 
method is a suitable technique for analysis of 
protein structural change in some cases, on the 
other hand CD findings confirmed relationship 
between glucose concentrations, temperature and 
Albumin conformational change; here UV spectra 
(see figures 4 and 5) are taken and compared with 
CD results. UV findingsindicate that albumin 
structure in the presence of sub threshold dosage 
of glucose has a flexible unit and responses to 
temperature alteration in pre-denaturation range, 
but arising glucose concentration to 400 mg/dl 
diminishes this ability of albumin. This finding 
verifies CD findings. To sum up, it is suggested 
that thermal conformational changes may be alike 
to conformational changes of albumin in the 





     It can be concluded that, high doses of glucose 
such as diabetic conditioncan possibly effect on 
albumin structure and function.It seems thatthis 
effect of glucose is similar to the effect of fever 
on structure and function of albumin. 
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